At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomised,Double-blind,Placebo-controlled,Multinational,Multi-centre,Phase IIb/III Study of the Efficacy and Safety of Three Doses of Sublingual Immunotherapy (SLIT) Administered as Tablets Once Daily to Patients Suffering From Grass Pollen Rhinoconjunctivitis
In Brief
A Phase 3 clinical trial evaluating 100 IR grass pollen allergen extract tablet, 300 IR grass pollen allergen extract tablet, and 2 other interventions for Allergy. Completed, enrolled 628 participants.
Detailed Summary
To evaluate the safety and efficacy of SLIT compared with placebo for reduction of symptoms and rescue medication usage
Study Details
Timeline
Interventions
One sublingual tablet daily during 4 months before pollen season and during pollen season
One sublingual tablet daily during 4 months before pollen season and during pollen season
One sublingual tablet daily during 4 months before pollen season and during pollen season
One sublingual tablet daily during 4 months before pollen season and during pollen season